Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Interest Coverage Ratio (2016 - 2024)

Sunshine Biopharma filings provide 11 years of Interest Coverage Ratio readings, the most recent being 238.92 for Q4 2024.

  • On a quarterly basis, Interest Coverage Ratio fell 505.93% to 238.92 in Q4 2024 year-over-year; TTM through Sep 2025 was 759.14, a 1129.11% decrease, with the full-year FY2024 number at 662.43, down 1800.74% from a year prior.
  • Interest Coverage Ratio hit 238.92 in Q4 2024 for Sunshine Biopharma, up from 5176.64 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.99 in Q2 2021 to a low of 858990.0 in Q3 2022.
  • Median Interest Coverage Ratio over the past 5 years was 26.56 (2024), compared with a mean of 48104.26.
  • Biggest five-year swings in Interest Coverage Ratio: plummeted 8109137.82% in 2022 and later skyrocketed 100.0% in 2023.
  • Sunshine Biopharma's Interest Coverage Ratio stood at 3.26 in 2020, then crashed by 134.44% to 7.63 in 2021, then crashed by 11429.02% to 880.12 in 2022, then soared by 95.52% to 39.43 in 2023, then crashed by 505.93% to 238.92 in 2024.
  • The last three reported values for Interest Coverage Ratio were 238.92 (Q4 2024), 5176.64 (Q2 2024), and 27.46 (Q1 2024) per Business Quant data.